Debt-to-equity of Coeptis Therapeutics Holdings, Inc. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
  • Coeptis Therapeutics Holdings, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 74%, a 83% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Coeptis Therapeutics Holdings, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 74% -352% -83% 30 Sep 2025
Q2 2025 97% -1334% -93% 30 Jun 2025
Q1 2025 137% -338% -71% 31 Mar 2025
Q4 2024 280% -25% -8.2% 31 Dec 2024
Q3 2024 426% +245% +136% 30 Sep 2024
Q2 2024 1431% +1300% +992% 30 Jun 2024
Q1 2024 475% +353% +289% 31 Mar 2024
Q4 2023 305% +203% +198% 31 Dec 2023
Q3 2023 181% +55% +44% 30 Sep 2023
Q2 2023 131% -1418% -92% 30 Jun 2023
Q1 2023 122% +356% 31 Mar 2023
Q4 2022 102% +245% 31 Dec 2022
Q3 2022 125% +296% 30 Sep 2022
Q2 2022 1550% 30 Jun 2022
Q1 2022 -234% 31 Mar 2022
Q4 2021 -143% 31 Dec 2021
Q3 2021 -170% 30 Sep 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.